For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

[1]  D. Chou,et al.  Magnesium sulphate versus diazepam for eclampsia. , 2010, The Cochrane database of systematic reviews.

[2]  D. Chou,et al.  Magnesium sulphate versus phenytoin for eclampsia. , 2010, The Cochrane database of systematic reviews.

[3]  B. Pfefferbaum,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. , 2001 .

[4]  Andrew R Willan,et al.  Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial , 2000, The Lancet.

[5]  B. Khoshnood,et al.  Perinatal Death and Tocolytic Magnesium Sulfate , 2000, Obstetrics and gynecology.

[6]  A. Gülmezoglu,et al.  Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.

[7]  K. M. Graham.  Magnesium sulphate in eclampsia , 1998, The Lancet.

[8]  A. Gülmezoglu,et al.  Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricians in the United Kingdom and Republic of Ireland , 1998, BMJ.

[9]  E. Coetzee,et al.  A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia , 1998, British journal of obstetrics and gynaecology.

[10]  J. Carlin,et al.  Tocolytic magnesium sulphate and paediatric mortality , 1998, The Lancet.

[11]  K. Nelson.  Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants. , 1996, JAMA.

[12]  R. Fox,et al.  Prefer diazepam for initial control of pre-eclampsic fits , 1995, BMJ.

[13]  J. Roberts.  Magnesium for preeclampsia and eclampsia. , 1995, The New England journal of medicine.

[14]  K. Leveno,et al.  A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. , 1995, The New England journal of medicine.

[15]  The Surfaxin-Lavage for Mas Trial Group.  Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[16]  C. Redman,et al.  Eclampsia in the United Kingdom , 1994, BMJ.

[17]  E. Shalev,et al.  The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade , 1994, British journal of obstetrics and gynaecology.

[18]  James M. Roberts,et al.  Pre-eclampsia: more than pregnancy-induced hypertension , 1993, The Lancet.

[19]  M. Belfort,et al.  Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo‐controlled study , 1993, American journal of obstetrics and gynecology.

[20]  L. Duley.  Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean , 1992, British journal of obstetrics and gynaecology.

[21]  S. Bergström,et al.  Seasonal incidence of eclampsia and its relationship to meteorological data in Mozambique. , 1992, Journal of perinatal medicine.

[22]  M. Sadeh,et al.  Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. , 1989, Stroke.

[23]  S. Finkbeiner,et al.  Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. , 1988, The New England journal of medicine.

[24]  L. M. Mayorga,et al.  Magnesium Plus Nifedipine: Potentiation of Hypotensive Effect in Preeclampsia? , 1988, American journal of obstetrics and gynecology.

[25]  Crowther Ca,et al.  Eclampsia at Harare Maternity Hospital. An epidemiological study. , 1985 .

[26]  J. Pritchard,et al.  The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. , 1984, American journal of obstetrics and gynecology.

[27]  J. Wigglesworth,et al.  MONITORING PERINATAL MORTALITY A Pathophysiological Approach , 1980, The Lancet.

[28]  F. Zuspan.  Problems encountered in the treatment of pregnancy-induced hypertension. A point of view. , 1978, American journal of obstetrics and gynecology.